课题基金 / 基金详情

REGULATORY MANAGEMENT CENTER (RMC) - Infectious Diseases

REGULATORY MANAGEMENT CENTER (RMC) - Infectious Diseases
监管管理中心 (RMC) - 传染病
批准号:
10666940
负责人:
MATTHEW KIRKBY
金额:
$199.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-11-01 至 2022-10-31

项目摘要

项目成果

MATTHEW KIRKBY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this contract is to establish a Division-wide Regulatory Management Center to: (1) centralize all regulatory support services for DAIT-funded clinical research programs, currently carried out under multiple grants and contracts, into a single contract dedicated to regulatory affairs; (2) provide regulatory support services for individual clinical trial projects conducted under investigator-initiated cooperative agreement grants within a centralized contract; and (3) provide regulatory support services for future DAIT-supported clinical research programs and individual projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE CONTINUUM OF CARE IN HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER AND INFECTIOUS COMPLICATIONS OF DRUG USE (CHOICE)
  • 批准号:
    10717509
  • 项目类别:
  • 资助金额:
    $233.0万
  • 财政年份:
    2021
  • 负责人:
    MATTHEW KIRKBY
  • 依托单位:
REGULATORY MANAGEMENT CENTER (RMC)
  • 批准号:
    10672004
  • 项目类别:
  • 资助金额:
    $100.0万
  • 财政年份:
    2021
  • 负责人:
    MATTHEW KIRKBY
  • 依托单位:
REGULATORY MANAGEMENT CENTER (RMC) - Infectious Diseases
  • 批准号:
    10788219
  • 项目类别:
  • 资助金额:
    $419.75万
  • 财政年份:
    2021
  • 负责人:
    MATTHEW KIRKBY
  • 依托单位:
CLINICAL CENTRAL LABORATORY SERVICES
  • 批准号:
    10397350
  • 项目类别:
  • 资助金额:
    $2.5万
  • 财政年份:
    2021
  • 负责人:
    MATTHEW KIRKBY
  • 依托单位:
海外基金